Inmagene to join Nasdaq through reverse merger with Ikenanews2024-12-23T14:55:44+00:00December 23rd, 2024|Endpoints News|
Sofinnova outlines $550M fund after IPOs and M&A dealsnews2024-12-20T16:08:52+00:00December 20th, 2024|Endpoints News|
Florida cancer biotech Syncromune raises $100M Series Anews2024-12-20T11:30:38+00:00December 20th, 2024|Endpoints News|
David Epstein gets $140M for Ottimo’s bifunctional take on hot PD-1xVEGF fieldnews2024-12-19T07:25:41+00:00December 19th, 2024|Endpoints News|
Ring Therapeutics cuts workforce in latest round of layoffs as CEO departsnews2024-12-18T14:58:47+00:00December 18th, 2024|Endpoints News|
SiteOne Therapeutics, a pain biotech that’s partnered with Vertex, nabs $100Mnews2024-12-18T12:00:41+00:00December 18th, 2024|Endpoints News|
Chicago’s biotech scene is growing up. What’s fueling it?news2024-12-17T15:28:21+00:00December 17th, 2024|Endpoints News|
Shinobi adds Borges as science chief, Katz as top medical officernews2024-12-17T11:00:56+00:00December 17th, 2024|Endpoints News|
Food as medicine could get boost from Trump presidencynews2024-12-16T22:10:31+00:00December 16th, 2024|Endpoints News|
